NASDAQ:BLAC Bellevue Life Sciences Acquisition (BLAC) Stock Price, News & Analysis → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free BLAC Stock Alerts $10.71 -0.01 (-0.09%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$10.71▼$10.7350-Day Range$10.58▼$10.8352-Week Range$10.15▼$11.16Volume1,068 shsAverage Volume41,836 shsMarket Capitalization$60.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Get Bellevue Life Sciences Acquisition alerts: Email Address Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read About Bellevue Life Sciences AcquisitionBellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Read More BLAC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BLAC Stock News HeadlinesApril 21, 2023 | wsj.comBellevue Life Sciences Acquisition Corp.April 18, 2023 | seekingalpha.comBLACW Bellevue Life Sciences Acquisition Corp. WT EXP 020928See More Headlines Receive BLAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bellevue Life Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:BLAC CUSIPN/A CIK1840425 Webwww.bellevuespac.com Phone425-635-7700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares5,620,000Free Float4,740,000Market Cap$60.20 million OptionableNot Optionable Beta-0.03 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Kuk Hyoun Hwang (Age 47)CEO & Director Mr. David Jin Yoo (Age 50)Chief Financial Officer Key CompetitorsCorner Growth Acquisition Corp. 2NASDAQ:TRONCactus Acquisition Corp. 1NASDAQ:CCTSInception Growth AcquisitionNASDAQ:IGTAJVSPAC AcquisitionNASDAQ:JVSAHHG CapitalNASDAQ:HHGCView All CompetitorsInstitutional OwnershipWealthspring Capital LLCSold 32,684 shares on 4/18/2024Ownership: 0.606%Karpus Management Inc.Sold 16,600 shares on 2/13/2024Ownership: 0.956%Condor Capital ManagementBought 11,570 shares on 2/12/2024Ownership: 0.128%Mizuho Securities USA LLCBought 133,495 shares on 2/8/2024Ownership: 1.473%Cowen AND Company LLCBought 15,750 shares on 2/8/2024Ownership: 0.174%View All Institutional Transactions BLAC Stock Analysis - Frequently Asked Questions How have BLAC shares performed in 2024? Bellevue Life Sciences Acquisition's stock was trading at $10.50 at the beginning of the year. Since then, BLAC stock has increased by 2.0% and is now trading at $10.7120. View the best growth stocks for 2024 here. Are investors shorting Bellevue Life Sciences Acquisition? Bellevue Life Sciences Acquisition saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,200 shares, an increase of 46.7% from the March 31st total of 1,500 shares. Based on an average trading volume of 23,800 shares, the short-interest ratio is presently 0.1 days. Approximately 0.1% of the shares of the company are sold short. View Bellevue Life Sciences Acquisition's Short Interest. Who are Bellevue Life Sciences Acquisition's major shareholders? Bellevue Life Sciences Acquisition's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wealthspring Capital LLC (0.61%). How do I buy shares of Bellevue Life Sciences Acquisition? Shares of BLAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BLAC) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Life Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.